Plandai Biotech
Plandaí Biotechnology, Inc. does not have significant operations. Previously, it was involved in a biotechnology-related business. Plandaí Biotechnology, Inc. is based in Taipei, Taiwan.
Plandai Biotech (PLPL) - Net Assets
Latest net assets as of September 2024: $-58.78K USD
Based on the latest financial reports, Plandai Biotech (PLPL) has net assets worth $-58.78K USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($100.00K) and total liabilities ($158.78K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-58.78K |
| % of Total Assets | -58.78% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Plandai Biotech - Net Assets Trend (2003–2024)
This chart illustrates how Plandai Biotech's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Plandai Biotech (2003–2024)
The table below shows the annual net assets of Plandai Biotech from 2003 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | $-55.00K | +87.57% |
| 2023-06-30 | $-442.64K | +71.00% |
| 2022-06-30 | $-1.53 Million | +20.24% |
| 2021-06-30 | $-1.91 Million | +89.92% |
| 2020-06-30 | $-18.98 Million | -26.88% |
| 2017-06-30 | $-14.96 Million | -24.83% |
| 2016-06-30 | $-11.98 Million | -44.08% |
| 2015-06-30 | $-8.32 Million | -134.98% |
| 2014-06-30 | $-3.54 Million | -1.58% |
| 2013-06-30 | $-3.48 Million | -1103.43% |
| 2012-06-30 | $-289.54K | +94.28% |
| 2011-06-30 | $-5.06 Million | -12.39% |
| 2010-06-30 | $-4.50 Million | -21.75% |
| 2009-06-30 | $-3.70 Million | -21.35% |
| 2008-06-30 | $-3.05 Million | -60.30% |
| 2007-06-30 | $-1.90 Million | +15.61% |
| 2006-06-30 | $-2.25 Million | -7.25% |
| 2005-06-30 | $-2.10 Million | -140.66% |
| 2004-06-30 | $-872.39K | 0.00% |
| 2003-06-30 | $-872.39K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Plandai Biotech's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4227298000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.49 Million | % |
| Other Comprehensive Income | $170.17K | % |
| Other Components | $39.31 Million | % |
| Total Equity | $-55.00K | 100.00% |
Plandai Biotech Competitors by Market Cap
The table below lists competitors of Plandai Biotech ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
OL GROUPE
MU:XXT
|
$17.95K |
|
eMan a.s.
PR:EMAN
|
$17.95K |
|
SOLARWORLD ENERGY SOL LTD
NSE:SOLARWORLD
|
$17.96K |
|
Harrison Vickers and Waterman Inc
PINK:HVCW
|
$17.98K |
|
aReit Prop Ltd
JSE:APO
|
$17.94K |
|
Stans Energy Corp
PINK:HREEF
|
$17.94K |
|
Helios Underwriting PLC
LSE:HUW
|
$17.93K |
|
Cash.Medien AG
HM:MF8
|
$17.93K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Plandai Biotech's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -442,644 to -55,000, a change of 387,644.
- Net income of 16,029,000 contributed positively to equity growth.
- Share repurchases of 3,925,033 reduced equity.
- Other comprehensive income decreased equity by 3,925,034.
- Other factors decreased equity by 7,791,289.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $16.03 Million | +29143.64% |
| Share Repurchases | $3.93 Million | -7136.42% |
| Other Comprehensive Income | $-3.93 Million | -7136.43% |
| Other Changes | $-7.79 Million | -14165.98% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Plandai Biotech's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-06-30 | $-294.33 | $0.00 | x |
| 2004-06-30 | $-294.33 | $0.00 | x |
| 2005-06-30 | $-84.67 | $0.00 | x |
| 2006-06-30 | $-79.43 | $0.00 | x |
| 2007-06-30 | $-59.82 | $0.00 | x |
| 2008-06-30 | $-90.22 | $0.00 | x |
| 2009-06-30 | $-0.65 | $0.00 | x |
| 2010-06-30 | $-0.42 | $0.00 | x |
| 2011-06-30 | $-0.45 | $0.00 | x |
| 2012-06-30 | $0.00 | $0.00 | x |
| 2013-06-30 | $-0.02 | $0.00 | x |
| 2014-06-30 | $-0.02 | $0.00 | x |
| 2015-06-30 | $-0.06 | $0.00 | x |
| 2016-06-30 | $-0.07 | $0.00 | x |
| 2017-06-30 | $-0.05 | $0.00 | x |
| 2020-06-30 | $-0.02 | $0.00 | x |
| 2021-06-30 | $0.00 | $0.00 | x |
| 2022-06-30 | $0.00 | $0.00 | x |
| 2023-06-30 | $0.00 | $0.00 | x |
| 2024-06-30 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Plandai Biotech utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | 0.00% | -15.37% | 3.14x | 0.00x | $-734.76K |
| 2004 | 0.00% | -11.76% | 4.63x | 0.00x | $-840.31K |
| 2005 | 0.00% | -15.13% | 5.47x | 0.00x | $-1.31 Million |
| 2006 | 0.00% | -4.66% | 5.59x | 0.00x | $-371.82K |
| 2007 | 0.00% | -7.68% | 4.87x | 0.00x | $-788.97K |
| 2008 | 0.00% | -16.81% | 9.60x | 0.00x | $-1.59 Million |
| 2009 | 0.00% | -12.86% | 7.31x | 0.00x | $-455.34K |
| 2010 | 0.00% | -9.71% | 4.95x | 0.00x | $-379.92K |
| 2011 | 0.00% | -7.65% | 7.60x | 0.00x | $-42.16K |
| 2012 | 0.00% | -5073.07% | 0.01x | 0.00x | $-3.75 Million |
| 2013 | 0.00% | -609.23% | 0.04x | 0.00x | $-1.93 Million |
| 2014 | 0.00% | -5872.86% | 0.03x | 0.00x | $-15.39 Million |
| 2015 | 0.00% | -10315.03% | 0.01x | 0.00x | $-8.93 Million |
| 2016 | 0.00% | -10314.54% | 0.01x | 0.00x | $-8.60 Million |
| 2017 | 0.00% | -972.84% | 0.06x | 0.00x | $-2.67 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $1.61 Million |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $520.45K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $6.98 Million |
| 2023 | 0.00% | -6633.55% | 0.00x | 0.00x | $-19.76 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $16.03 Million |
Industry Comparison
This section compares Plandai Biotech's net assets metrics with peer companies in the Specialty Business Services industry.
Industry Context
- Industry: Specialty Business Services
- Average net assets among peers: $772,489,888
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Plandai Biotech (PLPL) | $-58.78K | 0.00% | N/A | $17.95K |
| All American Pet Co (AAPT) | $-1.12 Million | 0.00% | 0.00x | $0.97 |
| ABM Industries Incorporated (ABM) | $61.90 Million | 11.47% | 1.78x | $2.27 Billion |
| ADM Endeavors Inc (ADMQ) | $284.02K | -124.30% | 3.55x | $3.87 Million |
| Amentum Holdings Inc. (AMTM) | $4.55 Billion | -1.80% | 1.63x | $4.20 Billion |
| Anacomp Inc (ANMP) | $101.14 Million | -0.68% | 0.63x | $976.94K |
| Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | $5.65 Million | 2.35% | 0.50x | $30.94 Million |
| Applus Services S.A (APLUF) | $642.95 Million | 7.56% | 2.78x | $16.82 Million |
| ARC Document Solutions Inc (ARC) | $-35.01 Million | 0.00% | 0.00x | $110.98 Million |
| Aramark Holdings (ARMK) | $2.75 Billion | -16.80% | 4.72x | $10.51 Billion |
| Atento S.A. (ATTOF) | $-348.87 Million | 0.00% | 0.00x | $945.48 |